TY  - CONF

T1  - Abstract P1-17-01: Long term survival benefits of adjuvant zoledronic acid associated with maf status of primary tumor

JO  - Cancer Research

PY  - 2019/02/15

AU  - Coleman R

AU  - Gregory W

AU  - Jean-Mairet J

AU  - Tercero JC

AU  - Torres-Martin J

AU  - Gomis R

ED  - 

DO  - DOI: 10.1158/1538-7445.sabcs18-p1-17-01

PB  - American Association for Cancer Research (AACR)

VL  - 79

IS  - 4_Supplement

Y2  - 2025/10/10

ER  -